Acromegaly in Carney complex
- 90 Downloads
Carney complex (CNC) is a rare autosomal dominant syndrome, characterized by mucocutaneous pigmentation, cardiac, cutaneous myxomas and endocrine overactivity. It is generally caused by inactivating mutations in the PRKAR1A (protein kinase cAMP-dependent type I regulatory subunit alpha) gene. Acromegaly is an infrequent manifestation of CNC, reportedly diagnosed in 10% of patients.
We here report the case of a patient who was concomitantly diagnosed with Carney complex, due to a new mutation in PRKAR1A ((NM_002734.3:c.80_83del, p.(Ile27Lysfs*101 in exon 2), and acromegaly. In parallel, we conducted an extensive review of published case reports of acromegaly in the setting of CNC.
The 43-year-old patient was diagnosed with an acromegaly due to a GH-secreting pituitary microadenoma resistant to somatostatin analogs. He underwent transsphenoidal surgery in our tertiary referral center, which found a pure GH-secreting adenoma. In the literature, we identified 57 cases (24 men, 33 women) of acromegaly in CNC patients. The median age at diagnosis was 28.8 ± 12 year and there were 6 cases of gigantism. Acromegaly revealed CNC in only 4 patients. 24 patients had a microadenoma and two carried pituitary hyperplasia and/or multiple adenomas, suggesting that CNC may result in a higher proportion of microadenoma as compared to non-CNC acromegaly.
Although it rarely reveals CNC, acromegaly is diagnosed at a younger age in this setting, with a higher proportion of microadenomas.
KeywordsAcromegaly Carney complex PRKAR1A Microadenoma Myxoma
Compliance with ethical standards
Conflict of interest
All the author declare that they have no conflict of interest.
This article does not contain any studies with animals and human participants performed by any of the authors.
Informed consent was obtained from all individual participants included in the study.
- 4.Bertherat J, Horvath A, Groussin L et al (2009) Mutations in regulatory subunit type 1A of cyclic adenosine 5′-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes. J Clin Endocrinol Metab. https://doi.org/10.1210/jc.2008-2333 Google Scholar
- 15.Pack SD, Kirschner LS, Pak E et al (2000) Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the “complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas” (Carney complex). J Clin Endocrinol Metab 85:3860–3865. https://doi.org/10.1210/jcem.85.10.6875 Google Scholar
- 20.Leedman PJ, Cohen AK, Matz LR (1986) The complex of myxomas, spotty pigmentation and endocrine overactivity. Clin Endocrinol (Oxf) 25:527–534. https://doi.org/10.1111/j.1365-2265.1986.tb03605.x CrossRefGoogle Scholar
- 24.Gennari M, Stratakis CA, Hovarth A et al (2008) A novel PRKAR1A mutation associated with hepatocellular carcinoma in a young patient and a variable Carney complex phenotype in affected subjects in older generations. Clin Endocrinol (Oxf) 69:751–755. https://doi.org/10.1111/j.1365-2265.2008.03286.x CrossRefGoogle Scholar
- 35.Pandolfino TL, Cotell S, Katta R (2001) Pigmented vulvar macules as a presenting feature of the Carney complex. Int J Dermatol 40:728–730. https://doi.org/10.1046/j.1365-4362.2001.01281-5.x CrossRefGoogle Scholar
- 43.Takano K, Yasufuku-Takano J, Morita K et al (2009) Evidence that PKA activity is constitutively activated in human GH-secreting adenoma cells in a patient with Carney complex harbouring a PRKAR1A mutation. Clin Endocrinol (Oxf) 70:769–775. https://doi.org/10.1111/j.1365-2265.2008.03457.x CrossRefGoogle Scholar
- 49.Akin S, Noyan S, Dagdelen S et al (2017) Unusual presentations of Carney complex in patient with a novel PRKAR1A mutation. Neuro Endocrinol Lett 38:248–254Google Scholar